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Objectives: To analyze the prevalence of Calciﬁc Aortic Valve Disease (CAVD) in
the Chinese population.
Methods: Data was collected from Echocardiogram reports of subjects who had been
examined in the Cardiology Department of our hospital spanning a period of eight
years; from January 2005 to December 2012.The data collected was then analyzed
using statistical methods Independent t Test and Chi Square tests of SPSS 13.0 of IBM
SPSS Statistics. The level of signiﬁcance was set at 99% Conﬁdence Interval.
Results: The total number of subjects aged 45 years was (n¼17826), men (n¼9725,
54.6%). The estimated prevalence in our study subjects for individuals 45 years and
older was 12.8% (99% CI, 12.1%-13.4%), the estimated prevalence among men was
13.6% (99%, 12.7%-14.5%) and that among women was 11.9% (99%CI, 11%-
12.8%). The mean age of prevalence for men was (7010) years and for women was
(71 10) years. We observed a dramatic increase of prevalence with advancing age,
the four age groups 45-64, 65-74, 75-84 and 85 years old or older, had the prevalence
of 5.3%, 20.5% 32.9% and 54.4% respectively. For individuals aged 65 years and
older the estimated prevalence was 25.7% approximately equivalent to that estimated
in the western population. At the time of examination, stenosis ranging from mild to
severe had already set in 15% of those with CAVD. Regurgitation of the aortic valves
was the most frequent functional abnormality observed and the most frequent involved
leaﬂet was the noncoronary valve leaﬂet. Hypertension had the closest association
with CAVD, 27% of subjects in the CAVD group were hypertensive. A signiﬁcant
association was also observed between CAVD and CHD.
Conclusions: This study shows that, prevalence of CAVD in the Chinese population
does not differ from that already observed in the Western population, the prevalence of
CAVD showed a signiﬁcant increase as age increases. Hypertension has a closest
association with CAVD; therefore effective control of hypertension may help delay
the onset or control the progression of CAVD.
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Objectives: Junctophilin-2 (JP2) is a membrane-binding protein coupling between
plasma membrane L-type Ca2+ channels and sarcoplasmic reticular ryanodine re-
ceptors (Ryr) in cardiac myocytes which regulate intracellular calcium stability.
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal
intracellular calcium-handling. The aim of this study was to investigate whether the
changes of JPH2 contributes to the development of atrial ﬁbrillation (AF).
Methods: The mRNA level of JP2 was assayed by quantitative polymerase chain
reaction and the protein level of JP2 was determined using western blot analysis (12
atrial appendages from patients with sinus rhythm (SR) and 24 atrial appendages from
patients with Chronic AF (CAF).
Results: Our results identiﬁed that the JP2 protein was expressed in patients atrial
both in SR and CAF. The mRNA level was down-regulation in Patients atrial with
CAF (n¼24, P<0.01) compared with SR (n¼12). Consistent with the mRNA level,
the protein level of JP2 in CAF (n¼24) was decreased signiﬁcantly (P<0.01) than in
SR (n¼12). Our results showed that JP2 reduced the express in mRNA level and
protein level in patients with CAF.
Conclusions: Reduced levels of JP2 may contribute to excitation-contraction coupling
dysfunction in CAF, which induce abnormal intracellular calcium handling during AF.
Therefore, JP2 maybe as a new therapeutic strategy of patients with Atrial Fibrillation.
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Objectives: To determine the frequency of short term clinical outcomes of percuta-
neous transvenous mitral commissurotomy for mitral stenosis among patients having
wilkin score of <12.
Methods: This was a descriptive cross sectional study carried out at Cardiology Unit
Govt. Lady Reading Hospital Peshawar. Duration of study was nine months and
twenty days (July 01, 2012 - June 20, 2013) .Mitral stenosis patients with or without
pre existing mild mitral regurgitation admitted in Cardiology Unit, Lady Reading
Hospital Peshawar were included in the study. After performing PTMC according to
standard protocol, data regarding improvement in mitral valve area, pulmonary artery
pressure and severity of mitral regurgitation was recorded.
Results: Out of total 175 patients 56 (32%) were males. The mean age of the patients
was 22.697.93 years. Mean BMI of patients was 21.073.95. Mean Wilkin’s score
was 6.691.99 ranging from 3-11. Improvement in mitral valve area, pulmonary
artery pressure, mitral valve gradient and left atrial volume were found in 148 (84.6%) ,
170 (97.1%) , 175 (100%) and 170 (97.1%) respectively. While worsening in mitral
regurgitation was 47 (26.9%).
Conclusions: PTMC is a safe and effective procedure with good short term outcomes
like improvement in mitral valve area, pulmonary artery pressure, mitral valve
gradient and left atrial volume and not worsening mitral regurgitations in patients of
mitral stenosis having Wilkin’s score < 12.C196 JACC Vol 64/16/Suppl C j October 16–1Cardiomyopathy
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Objectives: In 1984, Fu Wai Hospital pioneered the surgical treatment of hypertro-
phic obstructive cardiomyopathy (HOCM) in China. In 2002 we evolved our septal
myectomy technique with wider septal resection to the base of both papillary muscles
without mitral valve leaﬂets treatment. This study was conducted to evaluate follow-
up Results in patients with HOCM who underwent modiﬁed Morrow procedure in
China.
Methods: Between 2002 and 2014, a total of 201 consecutive HOCM patients who
underwent modiﬁed Morrow procedure by the author in Fu Wai Hospital were
retrospectively recruited. The clinical effects were evaluated during the follow-up
period.
Results: Among 201 patients, 142 patients were treated with isolated modiﬁed
Morrow procedure, 59 patients who had other cardiac lesions underwent modiﬁed
Morrow procedure simultaneous associated cardiac procedures, including coronary
artery bypass graft, cardiac valve repair and replacement, repair of congenital heart
disease, radiofrequency ablation for atrial ﬁbrillation, right ventricular outﬂow tract
reconstruction and cardiac tumor resection. None of the patients died during the
operation. Cardiopulmonary bypass time was (85.231.1) minutes and aortic
clamping time was (55.221.2) minutes. The width, length and thickness of excised
septal myocardium were (43.29.3) mm, (44.48.5) mm and (11.02.7) mm,
respectively. After the operation, the left ventricular outﬂow tract (LVOT) pressure
gradient decreased from (92.230.4) mmHg to (16.09.9) mmHg (P<0.001). Mitral
regurgitation was signiﬁcantly improved, and 198 cases were trivial or no regurgita-
tion (P< 0.001). There were 6 (3%) patients received permanent pacemaker im-
plantation because of complete atrial-ventricular block, 3 (1.5%) underwent
concurrent ventricular septal perforation repair, 1 underwent apical anterior wall
perforation repair. 136 patients were followed-up (3 to 141 months) . During this
period, the average LVOT pressure gradient was at (14. 111.8) mmHg. 109 patients
were out of symptoms and were able to engage in daily housework or return to work.
The post-operative NYHA signiﬁcantly improved to (1.20.5) compared with
(2.90.4) preoperatively (P<0.001). HOCM related events were 4% including 4
patients of AF, 2 patients of myocardial ischemia, 1 patient of heart failure (HF), 1
patient of stroke accompanying HF with re-hospitalization. 1 patient died of Stanford
type A aortic dissection rupture 57 months after the operation.
Conclusions: Modiﬁed Morrow procedure across the aortic incision was an effective
treatment for HOCM. To excise thoroughly hypertrophic septal myocardium and
released papillary muscle were the key to improve the efﬁcacy of this operation.
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Objectives: Frequent premature ventricular complexes (PVCs) are associated with
left ventricular (LV) dysfunction. We performed a meta-analysis to evaluate the
effects of catheter ablation on improvement of LV function in patients with
frequent PVCs.
Methods: We searched MEDLINE for cohort studies of patients who underwent
catheter ablation of frequent PVCs. LV ejection fraction (LVEF) both before and
post-ablation was reported. The endpoints were changes from baseline in LVEF post-
ablation. Subgroup analysis of patients with LV dysfunction at baseline was
performed. Quantitative analysis of continuous variables was performed according to
random-effect Methods by MetaAnalyst Beta3.13 software. A 5% absolute increase
borderline in LVEF post-ablation for clinically signiﬁcance was prespeciﬁed. If the
lower limit of 95%CI of the overall mean change in LVEF post-ablation was beyond
the prespeciﬁed borderline, the effect of PVC ablation on LV function improvement
would be considered clinically signiﬁcant by 1-tailed student t test (0.05).
Results: Fifteen studies with 712 patients were included. The mean PVC burden
before catheter ablation was 24% [95% conﬁdence intervals (CIs): 19%–29%]. The
long-term success rate of PVC ablation ranged from 66%–90%. The overall mean
increase from baseline in LVEF post-ablation was 7.7% (95%CI: 6.1%–9.4%). The
student’s t test showed that the overall mean change in LVEF was beyond the
borderline of signiﬁcance (t value ¼ 3.23, p<0.05, Figure A). Subgroup analysis
showed that the overall mean increase from baseline in LVEF post-ablation was
12.4% (95%CI: 8.1%–16.6%) in patients with LV dysfunction at baseline. The stu-
dent’s t test showed that the overall mean change of LVEF in patients with LV
dysfunction at baseline was beyond the borderline of signiﬁcance (t value ¼ 3.44,
p<0.05, Figure B).9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
Conclusions: Ablation of frequent PVCs improves cardiac function, especially for
patients with LV dysfunction.
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Objectives: Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting
enzyme in regenerating nicotinamide adenine dinucleotide (NAD+) from nicotin-
amide. NAMPT has crucial roles for myocardial development, cardiomyocyte
energy metabolism and cell death/survival by regulating NAD+-dependent sirtuin-1
deacetylase. Serum NAMPT also functions as a potential inﬂammatory cytokine in
diverse biological contexts. The purpose of this study was to clarify the hypothesis
that SNPs of the NAMPT gene may affect the susceptibility and prognosis for DCM
patients and to describe the association of NAMPT expression with clinical features
of DCM.
Methods: Three SNPs of NAMPT, including rs61330082 in the promoter
region, rs2505568 and rs9034 in the 30untranslated region were genotyped by
polymerase chain reaction-restriction fragment length polymorphism method in 394
patients with DCM and 395 controls. Plasma NAMPT levels of 113 DCM patients and
137 controls were measured using commercial ELISA kits.
Results: Statistically signiﬁcant decreased DCM risk was found to be associated
with the A allele and AT genotype of rs2505568 (OR 0.48, 95% CI 0.35-0.67,
P<0.0001 and OR 0.44, 95% CI ¼0.31-0.62, P<0.0001 respectively). Rs9034 C
allele and CC genotype were also associated with decreased DCM risk
(OR 0.61, 95% CI 0.44-0.86, P¼0.005 and OR 0.58, 95% CI 0.40-0.83, P¼0.0027
respectively). There was no difference of the allele and genotype frequencies
of rs61330082 polymorphism between DCM and control groups. The rs9034 CT
genotype presented longer overall survival than CC genotype in both univariable
(HR: 0.59, 95% CI 0.39-0.89, P¼0.01) and multivariable survival analysis after
adjusting for age and sex (HR: 0.56, 95% CI 0.37-0.86, P¼0.007). NAMPT
expression was signiﬁcantly higher in the DCM group compared with controls
(6.69 4.97 and 3.711.21 ng/ml, P<0.0001) but not associated with 3 SNPs.
There were signiﬁcant increases of NAMPT levels in NYHA IV class group than
NYHA II/III class group and the controls (10.676.23, 4.592.17 and 3.711.21
ng/ml, all P<0.0001). The NAMPT levels in NYHA II/III class group were
signiﬁcantly increased compared to controls (4.592.17 and 3.711.21 ng/ml,
P¼0.005).
A signiﬁcant correlation between NAMPT levels and N-terminal pro brain natri-
uretic hormone (r ¼ 0.726, P<0.0001) was found. We also observed a signiﬁcant
correlation between NMAPT levels and left ventricular end-diastolic diameter
(r ¼ 0.296, P¼0.01) and left ventricular end-diastolic volume (r ¼ 0.294, P¼0.011).
There were no correlations between NAMPT levels and left ventricular stroke volume,
ejection fraction and fractional shortening (r ¼ 0.10, P¼0.39; r ¼ -0.107, P¼0.362;
r ¼ 0.027, P¼0.85).
Conclusions: SNPs of NAMPT might be a novel genetic biomarker for the risk and
prognosis of DCM. NAMPT expression was associated with the degree of heart
failure and the features of echocardiography in DCM patients. Our Results suggested
an important role for NAMPT in the pathogenesis of DCM.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e3420
Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic
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Objectives: Circulating N-terminal pro-B-type natriuretic peptide (NT pro-BNP), high-
sensitivity C-reactive protein (hs-CRP) and big endothelin (big-ET) have been shown to be
increased in heart failure and to contribute to both hemodynamic deterioration and cardio-
vascular remodeling. Here, we examined the prognostic value of the three neurohormones
at admission in a population of hospitalized patients with dilated cardiomyopathy (DCM).
Methods: This cohort study was undertaken in 622 hospitalized patients with DCM in
Fuwai Hospital from January 2005 to September 2011 (female 26.5%, 51.414.6
years old). Standard demographics, echocardiography and routine blood samples were
obtained shortly after admission. NT pro-BNP, hs-CRP and big-ET were measured,
and their concentrations in relation to all-cause mortality were assessed through a
mean follow-up of 2.61.6 years.
Results: Kaplan-Meier curves showed that the all-cause mortality rates were higher in
patients with NT pro-BNP>2247 pmol/L compared to patients with NT pro-
BNP<2247 pmol/L (11.9% vs 34.8%, log-rank c2¼35.588, P<0.001), in patients
with hs-CRP>3.90 mg/L compared to patients with hs-CRP<3.90 mg/L (12.8% vs
33.6%, log-rank c2¼39.662, P<0.001) and in patients with big-ET>0.95 pmol/L
compared to patients with big-ET <0.95 pmol/L (12.5% vs 31.0%, log-rank
c2¼17.890, P<0.001) . High circulating concentrations of NT pro-BNP (HR 2.217,
95% CI 1.015-4.846, P¼0.046) and hs-CRP (HR 1.922, 95% CI 1.236-2.988,
P¼0.004), but not big-ET, in addition to left atrial diameter and fasting blood glucose,
were independent predictors of the outcome deﬁned as all-cause mortality.
Conclusions: In a large population of patientswithDCM, the circulating concentrations of
NTpro-BNPandhs-CRP, but not big-ET,were independentmarkers of all-causemortality.
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Objectives: To analyze and summarise the characters of echocardiographic myocar-
dial mechanics in Chinese patients with cardiac involvement due to primary
amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) using transthoracic
echocardiography (TTE) with 2-dimensional velocity vector imaging (VVI) .
Methods: 30 patients with biopsy-proved conﬁrmed AL-cardiac amyloidosis, 30
patients with asymmetric hypertrophic cardiomyopathy and 30 age-matched healthy
volunteers were included in the study. The clinical characteristics were collected and
three groups underwent conventional TTE and VVI. TTE was used for the evaluation
of LV wall thickness, left atrial and ventricle size, systolic and diastolic function. VVI
was used for the evaluation of LV segments and walls endocardial (ENDO),
myocardial (MYO) and epicardial (EPI) longitudinal, circumferential and radial strain
(LS, CS and RS). AL-CA and HCM patients also underwent cardiac magnetic reso-
nance (CMR) to evaluate the late gadolinium enhancement (LGE) features.
Results: There were no statistic differences in clinical symptoms and physical signs
between AL-CA andHCMgroups. LVwall thickness, LA diameter, E/A ratio, Septal E/
e’ ratio and the prevalence of granular sparklingwere higher in bothAL-CA andHCM in
comparison with controls (P<0.001), but ejection fraction (EF) was lower in patients
with AL-CA in comparison with HCM and controls (40.47.8%, 56.65.5%,
604.0%, respectively). LV ENDO LS, ENDO CS and RS in 16 segments were
signiﬁcantly lower inAL-CAwhen comparedwithHCMand controls, however, LVEPI
LS, EPI CS in apical and mid segments were similar among patients with AL-CA, HCM
and controls. The difference between ENDO and EPI LS (ENDO-EPI LS) in all left
ventricle walls were signiﬁcantly lower in AL-CA in comparison with controls, how-
ever, those changes in HCMwere variable. The LGE of CMR also showed the different
features in AL-CA and HCM: AL-CA group showed subendocardial LGE almost in all
LV walls, but HCM group showed patchy LGE in a regional, multifocal distribution.
Conclusions: AL-CA is characterised by a remarkable reduction of ENDO LS, CS
and RS in LV segments and an uniform decrease of ENDO-EPI LS in all LV walls,
but the changes in HCM is variable.
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